Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 12 of 15
Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status
NCT00731874
MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions
NCT00749372
Survey of Housestaff Attitudes Toward Patient Care and Safety
NCT00845052
Cardiac Deformation: Correlation With Conventional Echocardiographic Hemodynamic Variables (An Intraoperative Study)
NCT00874991
Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)
NCT00754117
Imaginal Exposure & D-Cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
NCT00875342
Identification of Dominate Stressors in the Intensive Care Unit (ICU)
NCT00645008
Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery
NCT00645138
Acceptance and Commitment Therapy for Delusions
NCT00657631
Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors
NCT00713882
Uro-NIRS Clinical Study
NCT00706407
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
NCT00936312
Electronic Prescribing and Electronic Transmission of Discharge Medication Lists
NCT00603070
Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis
NCT00572065
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
NCT00601055
Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation
NCT00629122
High-frequency-ultrasound Annular Arrays for Ophthalmic Imaging
NCT00633854
Evaluating the Effects of EHRs, P4P and Medical Home Redesign in the Hudson Valley
NCT00793065
Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma
NCT00538824
Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons
NCT00627978
Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma
NCT00401817
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
NCT00538733
Lexapro for Major Depression in Patients With Epilepsy
NCT01244724
Effect of Supplementary Vitamins on Oxidant Gene Expression in the Lungs of Healthy Smokers
NCT00565214
Increasing Use of Mental Health Services
NCT00605358
Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 Antibody
NCT00538668
Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
NCT00603109
Taconic Health Information Network and Community (THINC)
NCT00225563
Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML
NCT00538876
Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
NCT00377832
Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
NCT00504972
Placement of Permanent Pacemaker Study
NCT00512161
Efficacy of Pregnenolone in Patients With Schizophrenia
NCT00615511
Effectiveness of Case Management Versus Case Management Plus Problem-solving Therapy to Treat Depression in Low-income Elders
NCT00540865
Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL
NCT00504751
Treatment Response of Geriatric Depression
NCT00754936
Dasatinib in Polycythemia Vera
NCT00538980
Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy
NCT00777114
Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction
NCT00539045
Neuroimaging the Effects of Intravenous Anesthetic on Amygdala Dependent Memory Processes
NCT00504894
Platelet Activation Markers in Pediatric Cardiac Surgery
NCT00450151
Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section
NCT00432991
SSRI Effects on Semen Parameters in Men
NCT00385762
Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer
NCT00385996
Cognitive Behavioral Treatment of Posttraumatic Stress Disorder Enhanced by Virtual Reality for Individuals With PTSD and Substance Abuse
NCT00656344
Cognitive Behavioral Therapy for Paranoia in Schizophrenia
NCT01704833
Comparison of Psychotherapy Programs to Treat Panic Disorder
NCT00353470
Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.
NCT00401960
The Effects of Potassium Citrate on Bone Metabolism
NCT00357331
Aprotinin Use and Renal Outcome in Hypothermic Bypass and Circulatory Arrest for Surgical Repair of Thoracic Aorta.
NCT00405093
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.